Sponsor or institution
Clinical trials and research at Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. that are recruiting, in China. By phase: Phase 1 (4), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| QT Interval Effects of FXS5626 Tablets in Healthy Adults | Phase 1 | Beijing, Beijing Municipality | Recruiting | Jul 10, 2026 |
| FXS0683 in relapsed or refractory blood cancers | Phase 1 | Tianjin, Tianjin Municipality | Recruiting | May 29, 2026 |
| Luvometinib plus Anlotinib in KRAS-mutated NSCLC | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | May 1, 2026 |
| Oral FXS5626 for active non-anterior non-infectious uveitis | Phase 2 | Chongqing, Chongqing Municipality | Recruiting | Apr 27, 2026 |
| Evaluating XS-04 for patients with relapsed or refractory blood cancers | Phase 1 | Beijing and 3 other locations | Recruiting | Feb 11, 2025 |
| XS-02 capsules in adults with advanced solid tumors | Phase 1 | Beijing, Beijing Municipality | Recruiting | Aug 1, 2024 |
All recruiting trials (6)
-
QT Interval Effects of FXS5626 Tablets in Healthy Adults
This study tests whether a single dose of FXS5626 affects the heart’s QT interval in healthy adults compared to placebo.
-
FXS0683 in relapsed or refractory blood cancers
This first‑in‑human study tests FXS0683 in adults with relapsed or refractory B‑cell lymphoma, AML, MDS, or ALL to see if it is safe, how the drug behaves in the body, and whether it shows any antitumor activity.
-
Luvometinib plus Anlotinib in KRAS-mutated NSCLC
This study tests whether the combination of luvometinib and anlotinib helps people with KRAS-mutated metastatic non-small cell lung cancer who have tried prior treatments.
-
Oral FXS5626 for active non-anterior non-infectious uveitis
This 24-week treatment will test whether taking oral FXS5626 twice daily helps adults with active non-anterior non-infectious uveitis and is safe for them.
-
Evaluating XS-04 for patients with relapsed or refractory blood cancers
This study is testing a new tablet called XS-04 to see if it is safe and how well it works for people with certain types of blood cancers that have come back or didn’t respond to other treatments.
-
XS-02 capsules in adults with advanced solid tumors
This early-stage study tests XS-02 capsules to see if they are safe and tolerable and to get an early sense of how the drug behaves and works in adults with advanced solid tumors.
Quick answers
How many clinical trials run by Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.